(Q24202844)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23152215%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

meta-analysis

0 references

title

Vitamin E for Alzheimer's dementia and mild cognitive impairment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23152215%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

0 references

1 reference

mild cognitive impairment

0 references

dementia

0 references

vitamin

0 references

cognitive dysfunction

1 reference

Nicolas Farina

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23152215%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Mokhtar Gad El Kareem Nasr Isaac

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23152215%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Annalie R Clark

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23152215%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Jennifer Rusted

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23152215%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Naji Tabet

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23152215%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

language of work or name

English

0 references

publication date

14 November 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23152215%20AND%20SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

17 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23152215%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23152215%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

page(s)

CD002854

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23152215%20AND%20SRC:MED&resulttype=core&format=json

Vitamin E paradox in Alzheimer's disease: it does not prevent loss of cognition and may even be detrimental.

17 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Vitamin E and donepezil for the treatment of mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

The neuroprotective effect of vitamin E on chronic sleep deprivation-induced memory impairment: the role of oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Reexamination of a meta-analysis of the effect of antioxidant supplementation on mortality and health in randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Combination therapy of acetylcholinesterase inhibitor and vitamin E in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Why vitamin E therapy fails for treatment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Efficacy of a vitamin/nutriceutical formulation for early-stage Alzheimer's disease: a 1-year, open-label pilot study with an 16-month caregiver extension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

A vitamin/nutriceutical formulation improves memory and cognitive performance in community-dwelling adults without dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Treatment of Alzheimer's disease with a cholinesterase inhibitor combined with antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Changes in vitamin E prescribing for Alzheimer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

A randomized pilot clinical trial of the safety of pioglitazone in treatment of patients with Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Effect of vitamin E administration on the elevated oxygen stress and the telomeric and subtelomeric status in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

The response of gamma vitamin E to varying dosages of alpha vitamin E plus vitamin C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

A randomized trial of vitamin E supplementation and cognitive function in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Vitamin E in aging, dementia, and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Adherence to nutritional recommendations and subsequent cognitive performance: findings from the prospective Supplementation with Antioxidant Vitamins and Minerals 2 (SU.VI.MAX 2) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

French adults' cognitive performance after daily supplementation with antioxidant vitamins and minerals at nutritional doses: a post hoc analysis of the Supplementation in Vitamins and Mineral Antioxidants (SU.VI.MAX) trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Antioxidant approaches for the treatment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Donepezil delays progression to AD in MCI subjects with depressive symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Memory improvements in elderly women following 16 weeks treatment with a combined multivitamin, mineral and herbal supplement: A randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Antioxidant clinical trials in mild cognitive impairment and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Donepezil versus vitamin E in Alzheimer's disease: Part 2: mild versus moderate-severe Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Vitamin E use is associated with improved survival in an Alzheimer's disease cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Fruit and vegetable intake and cognitive function in the SU.VI.MAX 2 prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Effects of walnut consumption on cognitive performance in young adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Efficacy of a vitamin/nutriceutical formulation for moderate-stage to later-stage Alzheimer's disease: a placebo-controlled pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Characteristics and performance of a modified version of the ADCS-CGIC CIBIC+ for mild cognitive impairment clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Effect of vitamin E treatment on progressive cognitive impairment in a patient with adult-onset ataxia: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Vitamin E forms in Alzheimer's disease: a review of controversial and clinical experiences

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Influence of apolipoprotein E varepsilon4 on rates of cognitive and functional decline in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Vitamin E protects nerve cells from amyloid beta protein toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Vitamin C and Vitamin E for Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Adverse effects of vitamin E by induction of drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Forecasting the global burden of Alzheimer’s disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Bias in treatment assignment in controlled clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Vitamin E deficiency in developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Dietary intake of antioxidants and risk of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Outcomes of mild cognitive impairment by definition: a population study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Protective effect of alpha-tocopherol on ischemic neuronal damage in the gerbil hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

A sharper Bonferroni procedure for multiple tests of significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Learning behaviour in chronic vitamin E-deficient and -supplemented rats: radial arm maze learning and passive avoidance response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Biomarkers of Alzheimer disease in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Lipid peroxidation and free radical scavengers in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Vitamin E protects against Alzheimer's amyloid peptide (25-35)-induced changes in neocortical synaptosomal membrane lipid structure and composition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

High plasma levels of vitamin E forms and reduced Alzheimer's disease risk in advanced age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

The relation between antioxidants and memory performance in the old and very old.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Clinical practice. Mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Trial of d-alpha-tocopherol in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Vitamin E supplementation in Alzheimer's disease, Parkinson's disease, tardive dyskinesia, and cataract: Part 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

A new rating scale for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Effects of vitamin E on stroke subtypes: meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Chronic antioxidant treatment improves the cognitive performance of aged rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Assessing patient dependence in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Clock drawing in Alzheimer's disease. A novel measure of dementia severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

The Behavior Rating Scale for Dementia of the Consortium to Establish a Registry for Alzheimer's Disease. The Behavioral Pathology Committee of the Consortium to Establish a Registry for Alzheimer's Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Concentrations of alpha-tocopherol and its quinone derivative in cerebrospinal fluid from patients with vascular dementia of the Binswanger type and Alzheimer type dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Vitamins C and E: beneficial effects from a mechanistic perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Vitamin e-coated tympanostomy tube insertion decreases the quantity of free radicals in tympanic membrane.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Effect of high doses of dietary vitamin E on the concentrations of vitamin E in several brain regions, plasma, liver, and adipose tissue of rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Increased oxidative damage in nuclear and mitochondrial DNA in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Vitamin E prevents the place learning deficit and the cholinergic hypofunction induced by AF64A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Plasma concentrations of vitamins A and E and carotenoids in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Vitamin E for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Vitamin E for Alzheimer's disease and mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Tocopherols and tocotrienols plasma levels are associated with cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

Oxidative stress in mild cognitive impairment and Alzheimer disease: a continuum

21 January 2018

2 references

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

21 January 2018

12 December 2020

Plasma susceptibility to free radical-induced antioxidant consumption and lipid peroxidation is increased in very old subjects with Alzheimer disease.

2 references

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

21 January 2018

12 December 2020

Vitamin E and Alzheimer disease: the basis for additional clinical trials

1 reference

12 December 2020

Vitamins, trace elements, and antioxidant status in dementia disorders

1 reference

12 December 2020

Endogenous antioxidant activities in relation to concurrent vitamins A, C, and E intake in dementia.

1 reference

12 December 2020

Effect of vitamins and aspirin on markers of platelet activation, oxidative stress and homocysteine in people at high risk of dementia

1 reference

12 December 2020

Relation of the tocopherol forms to incident Alzheimer disease and to cognitive change

1 reference

12 December 2020

Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases

1 reference

12 December 2020

Antioxidants in central nervous system diseases: preclinical promise and translational challenges.

1 reference

12 December 2020

Down syndrome and dementia: a randomized, controlled trial of antioxidant supplementation

1 reference

12 December 2020

Clinical Dementia Rating (CDR).

1 reference

12 December 2020

Vitamin E plus aspirin compared with aspirin alone in patients with transient ischemic attacks

1 reference

12 December 2020

Brain Regional Correspondence Between Alzheimer's Disease Histopathology and Biomarkers of Protein Oxidation

1 reference

12 December 2020

No evidence for systemic oxidant stress in Parkinson's or Alzheimer's disease

1 reference

12 December 2020

Actions of neurotoxic beta-amyloid on calcium homeostasis and viability of PC12 cells are blocked by antioxidants but not by calcium channel antagonists

1 reference

12 December 2020

Rationale and design of a multicenter study of selegiline and alpha-tocopherol in the treatment of Alzheimer disease using novel clinical outcomes. Alzheimer's Disease Cooperative Study

1 reference

12 December 2020

Cerebrospinal fluid levels of alpha-tocopherol (vitamin E) in Alzheimer's disease

1 reference

12 December 2020

A conceptual framework for the revision of the ICD-10 classification of mental and behavioural disorders

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002854.PUB3

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1002/14651858.CD002854.PUB3

2 references

Consolidated OpenCitations Corpus – April 2017

3130468

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23152215%20AND%20SRC:MED&resulttype=core&format=json

release_t2tjpf4mlzcjhak3lt6mhpwgja

17 February 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/t2tjpf4mlzcjhak3lt6mhpwgja

24 November 2022

mapped directly with Wikidata item

3130468

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23152215%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

2 references

Consolidated OpenCitations Corpus – April 2017

3130468